Announce Date | 08/11/2025 |
EPS Normalized Actual | $-0.16 (Beat by $0.04) |
EPS GAAP Actual | $-0.16 (Beat by $0.04) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 10/01/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.37 |
EPS GAAP Estimate | $-0.37 |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | -0.795 | -5.7 | -0.795 | -0.795 | 1 |
Dec 2028 | -0.67667 | -6.69 | -0.67667 | -0.67667 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.39 | -0.035 | 0B | NAN% | 0M |
FQ1 2025 (Mar 2025) | -0.21 | 0.125 | 0B | NAN% | 0M |
FQ4 2024 (Dec 2024) | -0.21 | 0.064 | 0B | NAN% | 0M |
FQ3 2024 (Sep 2024) | -0.25 | -0.25 | 0B | NAN% | 0M |
FQ2 2024 (Jun 2024) | -0.21 | -0.21 | 0B | NAN% | 0M |
FQ1 2024 (Mar 2024) | -0.49 | -0.49 | 0B | NAN% | 0M |
FQ4 2023 (Dec 2023) | -0.45 | -0.45 | 0B | NAN% | 0M |
FQ3 2023 (Sep 2023) | 0.005 | 0.005 | 0B | NAN% | 0M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.37
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | -0.1108 | -- | -0.1108 | -0.1108 | 1 |
FQ3 2027 (Sep 2027) | -0.1107 | -- | -0.1107 | -0.1107 | 1 |
FQ2 2027 (Jun 2027) | -0.1191 | -- | -0.1191 | -0.1191 | 1 |
FQ1 2027 (Mar 2027) | -0.1175 | -- | -0.1175 | -0.1175 | 1 |
FQ4 2026 (Dec 2026) | -0.23 | -- | -0.23 | -0.23 | 1 |
FQ3 2026 (Sep 2026) | -0.23 | -- | -0.23 | -0.23 | 1 |
FQ2 2026 (Jun 2026) | -0.22 | -77.27 | -0.22 | -0.22 | 1 |
FQ1 2026 (Mar 2026) | -0.195 | -7.69 | -0.195 | -0.195 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0B | -- | 0B | 0B | 0 |
FQ3 2027 (Sep 2027) | 0B | -- | 0B | 0B | 0 |
FQ2 2027 (Jun 2027) | 0B | -- | 0B | 0B | 0 |
FQ1 2027 (Mar 2027) | 0B | -- | 0B | 0B | 0 |
FQ4 2026 (Dec 2026) | 0B | -- | 0B | 0B | 0 |
FQ3 2026 (Sep 2026) | 0B | -- | 0B | 0B | 0 |
FQ2 2026 (Jun 2026) | 0B | -- | 0B | 0B | 0 |
FQ1 2026 (Mar 2026) | 0B | -- | 0B | 0B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
0
Revenue # of Misses
0
Revenue # of in-lines
8
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.355 | -0.39 | -0.035 | 8.97% |
FQ1 2025 (Mar 2025) | -0.335 | -0.21 | 0.125 | -59.52% |
FQ4 2024 (Dec 2024) | -0.274 | -0.21 | 0.064 | -30.48% |
FQ3 2024 (Sep 2024) | -0.25 | -0.25 | 100% | |
FQ2 2024 (Jun 2024) | -0.21 | -0.21 | 100% | |
FQ1 2024 (Mar 2024) | -0.49 | -0.49 | 100% | |
FQ4 2023 (Dec 2023) | -0.45 | -0.45 | 100% | |
FQ3 2023 (Sep 2023) | 0.005 | 0.005 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $0B | $0M | NAN% |
FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
FQ3 2023 (Sep 2023) | $0B | $0B | $0M | NAN% |